Literature DB >> 10971382

Towards a targeted, risk-based, antifungal strategy in neutropenic patients.

H G Prentice1, C C Kibbler, A G Prentice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10971382     DOI： 10.1046/j.1365-2141.2000.02014.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  29 in total

1.  Isolated subcutaneous cryptococcal abscess after a BEACOPP regimen for Hodgkin's lymphoma.

Authors:  L Rosset; M Toetsch; L Kaiser; C Helg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-19       Impact factor: 3.267

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients.

Authors:  Ercole Concia; Anna Maria Azzini; Michela Conti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials.

Authors:  Jing Wang; Ping Zhan; Rongfu Zhou; Jingyan Xu; Xiaoyan Shao; Yonggong Yang; Jian Ouyang
Journal:  Med Oncol       Date:  2009-10-30       Impact factor: 3.064

5.  Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted Treatment.

Authors:  John W Baddley; Senu Apewokin
Journal:  Curr Fungal Infect Rep       Date:  2008-05-30

6.  Invasive fungal infections in acute leukemia.

Authors:  Vijaya R Bhatt; George M Viola; Alessandra Ferrajoli
Journal:  Ther Adv Hematol       Date:  2011-08

7.  Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients.

Authors:  M Michallet; T Bénet; M Sobh; S Kraghel; M El Hamri; G Cannas; F E Nicolini; H Labussière; S Ducastelle; F Barraco; X Thomas; Y Chelghoum; M-C Nicolle; A-L Bienvenu; F Persat; F De Monbrison; S Picot; P Vanhems
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-10       Impact factor: 3.267

8.  Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.

Authors:  Gary D Peksa; Kathryn Schultz; Henry C Fung
Journal:  J Oncol Pharm Pract       Date:  2014-06-17       Impact factor: 1.809

Review 9.  Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerability.

Authors:  H G Prentice
Journal:  Support Care Cancer       Date:  2003-07-05       Impact factor: 3.603

10.  Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation.

Authors:  Joshua Wolf; Monica A Slavin
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.